| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 01/17/2007 | CN1897944A Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 01/17/2007 | CN1897941A Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 01/17/2007 | CN1295217C New asymmetric diaryl-methylamine intermediates for the preparation of diarylmethylpiperazines derivatives |
| 01/17/2007 | CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163942 Sulfonamide compounds for the treatment of neurodegenerative disorders |
| 01/16/2007 | CA2237842C Method of preparing 2-trifluoromethoxybenzene sulphonamide |
| 01/11/2007 | WO2007004077A2 Process for the preparation of tamsulosin |
| 01/11/2007 | WO2005079270A3 2-substituted and 4-substituted aryl nitrone compouds |
| 01/11/2007 | US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/11/2007 | US20070010536 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 01/11/2007 | DE112004001158T5 Fluorierte Sulfonamidverbindungen und daraus hergestellte Polymer-Elektrolytmembranen zur Verwendung in elektrochemischen Zellen Sulfonamide compounds and fluorinated polymer electrolyte membranes produced therefrom for use in electrochemical cells |
| 01/11/2007 | CA2607809A1 Process for the preparation of tamsulosin |
| 01/10/2007 | EP1741693A1 Process for production of optically active alcohols |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740530A2 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
| 01/10/2007 | CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 01/10/2007 | CN1894202A Benzoyl-substituted phenylalanine amides |
| 01/10/2007 | CN1891705A Method for preparing sulfimidic acid silver |
| 01/09/2007 | US7161033 E.g., 2S [[(N-methylamino)acetyl]amino]-N-[2R-hydroxy-3-[[(1,3-benzodioxol-5-yl)sulfonyl](2-methylpropyl)amino]-1S-(phenylmethyl)propyl]-3,3-dimethyl-butanamide; in particular as inhibitors of HIV protease |
| 01/09/2007 | US7161032 Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof |
| 01/09/2007 | US7161031 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 01/09/2007 | US7161022 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative |
| 01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/09/2007 | US7160874 Phenylalanine derivatives |
| 01/09/2007 | US7160870 Thrombopoietin mimetics |
| 01/04/2007 | WO2007002172A2 Hiv-1 protease inhibitors |
| 01/04/2007 | WO2006117662A3 Polymorphic forms of (r)-(-)-tamsulosin |
| 01/04/2007 | US20070004807 Methods using phenethanolamine derivatives for treatment of respiratory diseases |
| 01/04/2007 | US20070004806 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 01/04/2007 | US20070004799 Novel compounds for the treatment of obesity |
| 01/04/2007 | US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents |
| 01/04/2007 | US20070004704 Such as 6-Methyl-2-[4-(5-methyl-2-phenyl-oxazol-4-ylmethoxy)-benzenesulfonylamino]-benzoic acid which binds Peroxisome Proliferator-Activated Receptors; conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X |
| 01/04/2007 | CA2667445A1 Hiv-1 protease inhibitors |
| 01/03/2007 | EP1739079A1 Novel bis-para-phenylendiamins joined by a linker arm comprising a sulphur or nitrogen atom and their use in dyeing |
| 01/03/2007 | EP1737812A1 Methods of amination |
| 01/03/2007 | EP1737811A1 Cetp inhibitors |
| 01/03/2007 | CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 01/02/2007 | US7157589 such as fructopyranose sulfamate derivatives formed by reacting diacetone fructose with sulfury diamide in presence of water; antiepileptic agents |
| 01/02/2007 | US7157498 Diamines having a CaSR modulating activity |
| 01/02/2007 | US7157489 HIV protease inhibitors |
| 01/02/2007 | US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | CA2274464C Ketobenzamides as calpain inhibitors |
| 12/28/2006 | US20060293385 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid |
| 12/28/2006 | US20060293380 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 12/28/2006 | US20060293352 Phenoxiacetic acid derivatives |
| 12/28/2006 | US20060292452 Electrolyte solution for secondary battery and secondary battery using same |
| 12/27/2006 | EP1736467A1 Novel sulfonamide derivative |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1735274A1 Nonpeptide inhibitors of matrix metalloproteinases |
| 12/27/2006 | EP1735271A2 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex |
| 12/27/2006 | EP1735270A1 Diamino alcohols and their use as renin inhibitors |
| 12/27/2006 | EP1735268A1 Opioid receptor antagonists |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1654324B1 Sulphonamide anions as catalysts for nco oligomerisation |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 12/27/2006 | CN1886132A Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| 12/27/2006 | CN1884259A Process for preparing 2-methoxyl-5-amino sulfonyl methyl benzoate |
| 12/26/2006 | US7154737 Nonaqueous electrolyte, electrical double-layer capacitors, and nonaqueous electrolyte secondary cells |
| 12/26/2006 | US7153869 Substituted amino acids as erythropoietin mimetics |
| 12/21/2006 | WO2006135694A2 Uii-modulating compounds and their use |
| 12/21/2006 | WO2006134212A2 Preparation of tamsulosin hydrochloride from tamsulosi |
| 12/21/2006 | US20060287539 Chemical intermediates for production of sibutramine |
| 12/21/2006 | US20060287393 Novel compounds, their preparation and use |
| 12/21/2006 | US20060287389 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/21/2006 | US20060287286 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 12/21/2006 | CA2609574A1 Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives |
| 12/20/2006 | EP1734036A1 Process for preparation of tamsulosin and its derivatives |
| 12/20/2006 | EP1732903A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd |
| 12/20/2006 | EP1732884A1 Sulphonamide derivatives |
| 12/20/2006 | EP1732532A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor |
| 12/20/2006 | EP1456171B1 Substituted cyclohexane derivatives |
| 12/20/2006 | CN1882532A Aminoalkylamide substituted cyclohexyl derivatives |
| 12/14/2006 | WO2006132811A2 Ampa receptor potentiators |
| 12/14/2006 | WO2006131757A1 Process and compound |
| 12/14/2006 | WO2006131452A1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS |
| 12/14/2006 | WO2005089269A3 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
| 12/14/2006 | CA2611609A1 Ampa receptor potentiators |
| 12/14/2006 | CA2608511A1 Process and compound |
| 12/13/2006 | EP1730103A1 Formamide derivatives useful as adrenoceptor |
| 12/13/2006 | EP1729756A2 Novel pharmaceutical compositions |
| 12/13/2006 | CN1878746A N-substituted p-menthane carbosamided |
| 12/13/2006 | CN1878466A Biphenyl derivative or salt thereof, pest control agent containing the same as active ingredient |
| 12/13/2006 | CN1289475C N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders |
| 12/13/2006 | CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 12/13/2006 | CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same |
| 12/12/2006 | US7148259 hydroxyamidines; antibiotic resistance |
| 12/07/2006 | WO2006097817A9 N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain |
| 12/07/2006 | WO2006019358A3 Process for preparing tamsulosin |
| 12/07/2006 | WO2006006156A3 Compounds/methods for detection of medical disorders |
| 12/07/2006 | US20060276667 N-substituted p-menthane carboxamides |
| 12/07/2006 | US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 12/07/2006 | US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 12/06/2006 | EP1727790A1 Phenylaminoethanol derivatives as beta2 receptor agonists |
| 12/05/2006 | CA2307121C Dofetilide polymorphs |
| 11/30/2006 | WO2006126939A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |